Abstract: Vesicoureteral reflux, retrograde flow of urine from the bladder into the upper urinary tract, is one of the most common urological diagnoses in the pediatric population. Diagnosis and subsequent management of urinary reflux have become increasingly debated in the past decade, with divergent opinions over which patients should be evaluated for reflux, and when detected, which children should receive intervention. Although some argue that vesicoureteral reflux is a "phenotype" that often resolves without intervention, others contest that untreated reflux has the potential to cause irreversible renal damage over time. Voiding cystourethrogram images the urethra and bladder during both bladder filling and emptying, as well as the ureters and kidneys when reflux is present, and is considered the gold standard for diagnosing vesicoureteral reflux. Once detected, therapeutic options for urinary reflux are diverse, ranging from observation with or without low-dose antibiotic prophylaxis to a variety of operative interventions. Management should be based on a multitude of factors including patient age, risk of subsequent urinary tract infections, risk of renal parenchymal injury, a given child's projected clinical course and parental preference. Over the past two decades, investigators have elucidated many crucial voiding cystourethrogram findings in addition to grade that provide significant prognostic information and are useful in determining the best course of action for a child on a more individualized basis.
Introduction
VUR is a common urological diagnosis in children, with an estimated prevalence of 0.4-1.8% in the general pediatric population, and upwards of 30% in those with a history of febrile UTI. 1, 2 Upper urinary tract dilatation on prenatal imaging is also suggestive of VUR, with numerous studies reporting that reflux is present in 10-20% of children with antenatally detected hydronephrosis. 3 Primary VUR results from failure of the UVJ to function properly, and is frequently associated with both a short intramural tunnel and a laterally displaced ureteral orifice. Spontaneous improvement or resolution commonly occurs, and is thought to be a multifactorial process related to UVJ remodeling, elongation of the intravesical ureter and stabilization of bladder voiding dynamics over time. The clinical significance of primary VUR in the absence of both UTI and upper tract anomalies has been the investigative subject of numerous recent randomized controlled trials, and the source of ongoing debate amongst physicians in various associations. 4 Although the clinical impact of primary reflux might be divisive, voiding cystourethrogram remains the gold standard for VUR diagnosis. Because of the importance of information obtained from a VCUG, and the fact that the quality of this information can vary depending on the VCUG technique and radiology report, the AAP Sections on Urology and Radiology recently published a joint standardized VCUG protocol discussed herein.
When is a VCUG indicated?
Detection of primary VUR on VCUG is often prompted by the diagnosis of a febrile UTI. In a febrile child, UTI diagnosis requires both a positive UA and urine culture. 6 The method of obtaining a urine specimen is critical for accurate diagnosis. Urine specimen should be obtained either through sterile transurethral catheterization or suprapubic aspiration if a clean catch specimen is not feasible (i.e. in young patients not yet toilet-trained), as the diagnosis of UTI cannot be reliably established by a bagged specimen. In 2011, the AAP revised their practice parameters regarding the diagnosis and management of initial febrile UTIs in infants and young children aged 2-24 months. 7 In this revision, the criteria to accurately establish UTI diagnosis were modified, and at present the AAP calls for the presence of >50 000 CFU/mL of a given uropathogen on catheterized specimen, as well as white blood cells present on UA. The inclusion of pyuria was included to help distinguish a true UTI inducing a significant host response as opposed to only bacteriuria. These guidelines were reaffirmed by the AAP in 2016. In addition, it has been noted that limited data also exist to suggest in the presence of both fever and pyuria, a colony count as low as 10 000 CFU/mL might also be an acceptable threshold for the diagnosis of UTI in infants. 6, 8 In addition to altering the criteria for diagnosis of a UTI with reduced CFU, the updated AAP guidelines recommend that infants with initial febrile UTI undergo a RBUS, but state that a VCUG should not be routinely carried out unless indicated by the presence of abnormal sonographic findings (i.e. hydronephrosis, scarring) or atypical/complex clinical circumstances. The guidelines also suggest that additional work-up be considered if a child experiences recurrent febrile infections. It is very important for the clinician to know that ultrasonography has not been proven to be either sensitive or specific in detecting reflux, although some authors have cited findings that might be associated with reflux (i.e. parenchymal echogenicity or scarring, renal atrophy, alterations in corticomedullary differentiation, calyceal or ureteral dilatation and urothelial thickening). [9] [10] [11] On the contrary, several publications focusing on the utility of RBUS as a diagnostic tool in children with febrile UTI have concluded that sonography remains an inferior screening test for both pyelonephritis and VUR, and shows a poor correlation between US and VCUG findings. [12] [13] [14] [15] Children with VUR, even dilating reflux, often have a normal retroperitoneal US. RBUS and VCUG should therefore be considered complementary studies, as they each provide important, but different, information to the clinician. For this reason, although most pediatric urologists concur with the majority of action statements described in the updated AAP guidelines, the diagnostic imaging recommendations in young infants and children are contested. 16, 17 In line with this debate, the Section on Urology of the AAP expressed strong opposition to the AAP guidelines with respect to the omission of VCUG in the evaluation of infants with febrile UTI. 17 VUR has been associated with an increased risk of recurrent UTI and renal scarring, and potential for subsequent significant morbidity has placed emphasis on prompt diagnosis of pediatric UTI, as well as appropriate antibiotic therapy. Failure to effectively screen children with a febrile UTI for VUR might place young children with VUR at untoward risk of both recurrent UTIs and potential renal injury. In fact, the clinical benefit of intervening in children with reflux has been supported by two large, multiinstitutional studies. 18, 19 The RIVUR Trial, a 2-year, multiinstitutional, randomized, placebo-controlled study involving >600 young patients with VUR, showed that antimicrobial prophylaxis substantially reduced the risk of recurrent UTIs. 18 Likewise in 2010, the Swedish Reflux Study showed the benefit of both prophylactic antibiotics and endoscopic injection in reducing recurrent pyelonephritis and new renal scarring in a group of 1-year-old children with dilating VUR. 19 These well-done studies confirmed the role of antibiotic prophylaxis in reducing recurrent UTIs in children with VUR.
If VCUG, and potentially a VUR diagnosis, are deferred after an initial febrile UTI episode, families should be appropriately counseled regarding the risks and benefits of not obtaining a VCUG and of undiagnosed reflux. One important risk associated with delayed VUR diagnosis is the reduced surveillance of sequela, such as renal scarring. Although the incidence of significant comorbidities in children with VUR is often quite low at diagnosis, long-term follow up with respect to disease-specific morbidity is necessary, as decades might pass between the first renal-scaring pyelonephritis and development of hypertension or end-stage renal disease. Calderon-Margalit recently reported that congenital anomalies of the kidney and/or pyelonephritis in childhood are associated with an increased risk of end-stage renal disease decades later, even if renal function in these individuals is normal during adolescence. 20 It has been recommended that children with VUR undergo annual BP monitoring, and height and weight assessment, as well as UA for proteinuria/bacteriuria, with a culture if infection is suspected. 16 In those children where the diagnosis of VUR is delayed or never made, these recommendations are less likely to be observed. As prompt diagnosis and treatment of a febrile UTI can reduce the risk of renal scaring, clinicians following the AAP guidelines must be vigilant in ensuring that all potential subsequent UTIs are rapidly investigated and treated regardless of the presence or absence of VUR. Children with higher grades of VUR and UTI are at increased risk for developing pyelonephritis and renal scars. In addition, for those with recurrent UTIs, healthcare providers need to ensure that care is appropriately escalated, including a VCUG if it was not previously obtained. 21 The utility of routine VCUG in infants with antenatal hydronephrosis likewise remains a source of controversy. Hydronephrosis is a frequent abnormality detected on prenatal US (identified in 1-2% of fetuses), reflects a spectrum of possible uropathies and there currently is no clear evidence to support or avoid postnatal imaging for VUR in this cohort. Ureteral dilatation and higher grades (Society of Fetal Urology grades III and IV) of hydronephrosis have been associated with increased infections, but it remains questionable whether the identification and treatment of children diagnosed with VUR as part of antenatal hydronephrosis evaluation confers any clinical benefit. 3, 22, 23 Visible ureter and reduced renal length have been associated with high-grade VUR, and Visuri et al. suggest that these are the only children in whom a routine postnatal VCUG might be necessary. 24 Worsening findings on serial sonograms are associated with increased risk of genitourinary pathology and warrant additional imaging. A recently published multidisciplinary consensus statement recommends stratification into low-/moderate-/highrisk categories, with VCUG as an option for all children with antenatal dilatation of the urinary tract, but is indicated in those with more severe dilatation or other abnormalities -again highlighting the importance of individualized care. 25 How to perform a VCUG Voiding cystourethrography has unique ability to provide detailed information about both the anatomical and functional status of the urinary tract. However, the literature has shown significant variability among institutions regarding the VCUG protocol used, as well as inconsistent reporting of the findings from the VCUG between institutions. 26, 27 Although VUR grade is routinely reported, other crucial anatomical and functional findings are consistently underreported. Given the invasive and relatively unpleasant nature of a VCUG, it is important that as much information as possible is obtained and reported when these studies are carried out.
In addition to potential patient and parental distress associated with a VCUG, it also exposes the child to radiation, albeit at low doses. 28 The ALARA and Image Gently principles should be adhered to, minimizing radiation exposure while still obtaining high-quality images. 29, 30 Sedation or immobilization can be considered as long as these methods do not alter the ability of the child to void, which will impact the test outcomes. Patient and caregiver education, as well as a comfortable environment with child life specialists, have also been shown to reduce the stress associated with invasive testing. 31 Although the benefits generally outweigh the risks, it is logical to optimize the quality and consistency of data obtained from each VCUG, as it is an invasive study. While urinary reflux tends to improve or resolve over time, there remains a small percentage of children with persistent VUR who are at risk for recurrent febrile UTI, as well as hypertension, end-stage renal disease and so on from kidney injury. Routinely improving the quality of VCUGs and of reporting its findings might help identify these patients, as radiographic findings play a key role in determining management. To this end, the AAP Sections on Radiology and Urology initiated a consensus standardized VCUG protocol in 2016. 5 Toilet-trained children should be allowed to void before initiation of the study, and a small age-appropriate nonballoon catheter is placed using a sterile technique for retrograde filling of the bladder with contrast to body temperature. Post-void residual should be recorded. During cyclic filling, multiple spot images in the anteroposterior, oblique and lateral positions are obtained, as well as urethral images during voiding. Scout and post-void images should be obtained, and the maximum volume of contrast instilled along with the volume at which reflux occurs, reported. At least two voiding cycles are recommended in order to identify intermittent VUR or ureteral ectopia. VUR should be graded according to the International Reflux Study. 32 
Volume at which VUR occurs
The goal of VUR treatment includes prevention of recurrent febrile infections, prevention of renal injury, and limiting the morbidity of both treatment and follow up. 16 Factors influencing the decision to place a child on continuous antibiotic prophylaxis or surgically correct VUR thus include further risk of UTI, risk of developing new renal parenchymal scarring and likelihood of spontaneous reflux resolution. Various online calculators have been created to predict spontaneous reflux resolution; however, a universal management algorithm is lacking. [33] [34] [35] The bladder volume during a VCUG when the onset of reflux occurs has been shown to be an important factor for predicting the likelihood of spontaneous resolution independent of the VUR grade. The volume at onset of VUR needs to be normalized as a percentage of the patient's age predicted bladder capacity; when this is done, those with later onset of reflux show significantly higher resolution rates independent of grade compared with those that have onset of reflux at lower bladder volumes. [35] [36] [37] An example of the impact of volume at VUR onset on 1-and 2-year resolution rates is noted in Table 1 . 38 Clinicians and caregivers often opt for antibiotic prophylaxis or surgical intervention based on the likelihood of resolution, as well as anticipated clinical course, thereby placing an emphasis on the ability to predict the risk of recurrent febrile infections (Fig. 1) . Importantly, VUR occurring early in bladder filling is also associated with an increased risk of breakthrough febrile UTI, providing an additional objective measurement to help assess a given child's projected clinical course. 39 The clinical correlations associated with bladder volume at onset of reflux prompted the recommendation for the standard inclusion of this information in a VCUG report in the recently published standardized VCUG protocol. 5 
Ureteral diameter ratio
Known factors impacting the likelihood of spontaneous VUR resolution include the grade of reflux, age, laterality, presence of bladder and bowel dysfunction, renal scarring, bladder volume at which reflux occurs, and the degree of distal ureteral dilatation. Many of these same characteristics also contribute Note that children with VUR occurring at <50% of predicted bladder capacity for age were significantly more likely to have persistent reflux.
to ongoing UTI risk. An individualized approach that accounts for a patient's demographic, radiographic and clinical risk factors should thus guide VUR management. 16, 25, 40, 41 Despite the various factors contributing to the natural course of VUR, grade remains the gold standard descriptor of reflux that is often quoted as the most important predictor of clinical outcomes. However, the subjective nature of the VUR grading system results in both significant interobserver and intraobserver variability and discrepancies, particularly when evaluating intermediate reflux grades. 42, 43 This potential downfall of the grading system led in part to the development of the distal UDR as a more objective and predictive descriptor of VUR. Distal ureteral dilatation, defined as >7 mm on US, impacts VUR resolution, as well as the need for surgical intervention. 44, 45 With UDR, ureteral dilatation is normalized to control for patient size and radiographic magnification. UDR has been shown to have good interrater reliability among pediatric urologists, with significantly less clinically relevant variability between raters than VUR grade. 46 Recent work has also shown that UDR is more predictive of spontaneous resolution as well as breakthrough UTIs than VUR grade. [47] [48] [49] In fact, the addition of grade to predictive models using UDR resulted in a lowering of these models' predictive ability. This limitation of grade relative to UDR is thought to be secondary to the influence of upper tract anatomy on grade, whereas VUR resolution and breakthrough UTIs are more likely to be influenced by the UVJ anatomy and distal ureter, which is better reflected by UDR.
UDR is calculated by measuring the largest ureteral diameter on VCUG within the false pelvis (defined as the area below the most superior aspect of the iliac crest); this measurement is then divided by the distance from the bottom of the L1 vertebral body to the top of L3 to control for patient size and radiographic magnification (Fig. 2) . The UDR can be easily calculated if the standardized VCUG protocol and reporting recommendations are routinely followed.
Given the objective nature and utility in predicting both the likelihood of spontaneous resolution and breakthrough UTI, the authors recommend considering volume at VUR onset and UDR as adjuncts to grade when counseling families regarding management. If the recent VCUG protocols are adhered to, these variables are readily assessable. These two objective measurements permit improved prediction of both VUR resolution and breakthrough UTIs, which facilitate a more individualized approach to patient management. For example, in children with a low risk of UTI and high likelihood of spontaneous resolution, the physician might elect to avoid additional VCUGs, whereas for those at higher risk, appropriate management might require antibiotic prophylaxis with closer VCUG surveillance every 1-2 years, or even early surgical intervention.
Conclusions
Controversy persists regarding VCUG indications and optimal management of primary vesicoureteral reflux in the pediatric population. However, recent standardization of the VCUG protocol has created a consensus on how to best carry out this test. Both the volume at onset of VUR and the UDR are readily accessible from a standard VCUG, and have been shown to improve the ability to predict VUR resolution and breakthrough UTIs. This information allows clinicians to provide individualized patient care. In the near future, convenient web-based predictive models incorporating multiple predictive factors will be available to facilitate even further individualization of care for children with VUR.
